DeCara, J M <br/><br/>
Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card?  [electronic resource] 

 -  Chest  Feb 1998 
 - 261-3 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>0012-3692 
<br/><br/><label>Standard No.: </label>10.1378/chest.113.2.261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--chemistry<br/>Atrial Fibrillation--complications<br/>Biological Availability<br/>Cerebrovascular Disorders--prevention & control<br/>Chemistry, Pharmaceutical<br/>Clinical Trials as Topic<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Drugs, Generic--economics<br/>Humans<br/>Patient Selection<br/>Therapeutic Equivalency<br/>Thromboembolism--prevention & control<br/>Warfarin--chemistry